APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dalbavancin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dalbavancin Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchDalbavancin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dalbavancin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Dalbavancin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dalbavancin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dalbavancin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dalbavancin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dalbavancin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dalbavancin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dalbavancin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dalbavancin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dalbavancin include Sanofi, Novartis, Merck, Roche, Pfizer, GSK, Amgen, Abbvie and Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dalbavancin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dalbavancin, also provides the sales of main regions and countries. Of the upcoming market potential for Dalbavancin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dalbavancin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dalbavancin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dalbavancin sales, projected growth trends, production technology, application and end-user industry.

Dalbavancin Segment by Company

Sanofi

Novartis

Merck

Roche

Pfizer

GSK

Amgen

Abbvie

Johnson

Hayao

Gilead

Dalbavancin Segment by Type

Intravenous Therapy

Oral Type

Dalbavancin Segment by Application

Skin Infection

Soft Tissue Infection

Others

Dalbavancin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dalbavancin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dalbavancin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dalbavancin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dalbavancin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dalbavancin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dalbavancin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dalbavancin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Intravenous Therapy Major Manufacturers Table 3. Oral Type Major Manufacturers Table 4. Global Dalbavancin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Skin Infection Major Manufacturers Table 6. Soft Tissue Infection Major Manufacturers Table 7. Others Major Manufacturers Table 8. Dalbavancin Industry Trends Table 9. Dalbavancin Industry Drivers Table 10. Dalbavancin Industry Opportunities and Challenges Table 11. Dalbavancin Industry Restraints Table 12. Global Dalbavancin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Dalbavancin Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Dalbavancin Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Dalbavancin Revenue Market Share by Region (2021-2026) Table 16. Global Dalbavancin Revenue Market Share by Region (2027-2032) Table 17. Global Dalbavancin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Dalbavancin Sales by Region (2021-2026) & (k units) Table 19. Global Dalbavancin Sales by Region (2027-2032) & (k units) Table 20. Global Dalbavancin Sales Market Share by Region (2021-2026) Table 21. Global Dalbavancin Sales Market Share by Region (2027-2032) Table 22. Global Dalbavancin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Dalbavancin Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Dalbavancin Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dalbavancin Sales Market Share by Manufacturers (2021-2026) Table 26. Global Dalbavancin Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Dalbavancin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Dalbavancin Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Dalbavancin Manufacturers, Product Type & Application Table 30. Global Dalbavancin Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Dalbavancin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Dalbavancin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Dalbavancin Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Dalbavancin Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Dalbavancin Revenue Market Share by Type (2021-2026) Table 37. Global Dalbavancin Revenue Market Share by Type (2027-2032) Table 38. Global Dalbavancin Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Dalbavancin Sales by Type (2021-2026) & (k units) Table 40. Global Dalbavancin Sales by Type (2027-2032) & (k units) Table 41. Global Dalbavancin Sales Market Share by Type (2021-2026) Table 42. Global Dalbavancin Sales Market Share by Type (2027-2032) Table 43. Global Dalbavancin Price by Type (2021-2026) & (US$/unit) Table 44. Global Dalbavancin Price by Type (2027-2032) & (US$/unit) Table 45. Global Dalbavancin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Dalbavancin Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Dalbavancin Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Dalbavancin Revenue Market Share by Application (2021-2026) Table 49. Global Dalbavancin Revenue Market Share by Application (2027-2032) Table 50. Global Dalbavancin Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Dalbavancin Sales by Application (2021-2026) & (k units) Table 52. Global Dalbavancin Sales by Application (2027-2032) & (k units) Table 53. Global Dalbavancin Sales Market Share by Application (2021-2026) Table 54. Global Dalbavancin Sales Market Share by Application (2027-2032) Table 55. Global Dalbavancin Price by Application (2021-2026) & (US$/unit) Table 56. Global Dalbavancin Price by Application (2027-2032) & (US$/unit) Table 57. Sanofi Company Information Table 58. Sanofi Business Overview Table 59. Sanofi Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Sanofi Dalbavancin Product Portfolio Table 61. Sanofi Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Novartis Dalbavancin Product Portfolio Table 66. Novartis Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Merck Dalbavancin Product Portfolio Table 71. Merck Recent Development Table 72. Roche Company Information Table 73. Roche Business Overview Table 74. Roche Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Roche Dalbavancin Product Portfolio Table 76. Roche Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Pfizer Dalbavancin Product Portfolio Table 81. Pfizer Recent Development Table 82. GSK Company Information Table 83. GSK Business Overview Table 84. GSK Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. GSK Dalbavancin Product Portfolio Table 86. GSK Recent Development Table 87. Amgen Company Information Table 88. Amgen Business Overview Table 89. Amgen Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Amgen Dalbavancin Product Portfolio Table 91. Amgen Recent Development Table 92. Abbvie Company Information Table 93. Abbvie Business Overview Table 94. Abbvie Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Abbvie Dalbavancin Product Portfolio Table 96. Abbvie Recent Development Table 97. Johnson Company Information Table 98. Johnson Business Overview Table 99. Johnson Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Johnson Dalbavancin Product Portfolio Table 101. Johnson Recent Development Table 102. Hayao Company Information Table 103. Hayao Business Overview Table 104. Hayao Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Hayao Dalbavancin Product Portfolio Table 106. Hayao Recent Development Table 107. Gilead Company Information Table 108. Gilead Business Overview Table 109. Gilead Dalbavancin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Gilead Dalbavancin Product Portfolio Table 111. Gilead Recent Development Table 112. North America Dalbavancin Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Dalbavancin Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Dalbavancin Sales by Type (2021-2026) & (k units) Table 115. North America Dalbavancin Sales by Type (2027-2032) & (k units) Table 116. North America Dalbavancin Sales Price by Type (2021-2026) & (US$/unit) Table 117. North America Dalbavancin Sales Price by Type (2027-2032) & (US$/unit) Table 118. North America Dalbavancin Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Dalbavancin Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Dalbavancin Sales by Application (2021-2026) & (k units) Table 121. North America Dalbavancin Sales by Application (2027-2032) & (k units) Table 122. North America Dalbavancin Sales Price by Application (2021-2026) & (US$/unit) Table 123. North America Dalbavancin Sales Price by Application (2027-2032) & (US$/unit) Table 124. North America Dalbavancin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Dalbavancin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Dalbavancin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Dalbavancin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 128. North America Dalbavancin Sales by Country (2021-2026) & (k units) Table 129. North America Dalbavancin Sales by Country (2027-2032) & (k units) Table 130. North America Dalbavancin Sales Price by Country (2021-2026) & (US$/unit) Table 131. North America Dalbavancin Sales Price by Country (2027-2032) & (US$/unit) Table 132. United States Dalbavancin Revenue (2021-2032) & (US$ Million) Table 133. Canada Dalbavancin Revenue (2021-2032) & (US$ Million) Table 134. Mexico Dalbavancin Revenue (2021-2032) & (US$ Million) Table 135. Europe Dalbavancin Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Dalbavancin Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Dalbavancin Sales by Type (2021-2026) & (k units) Table 138. Europe Dalbavancin Sales by Type (2027-2032) & (k units) Table 139. Europe Dalbavancin Sales Price by Type (2021-2026) & (US$/unit) Table 140. Europe Dalbavancin Sales Price by Type (2027-2032) & (US$/unit) Table 141. Europe Dalbavancin Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Dalbavancin Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Dalbavancin Sales by Application (2021-2026) & (k units) Table 144. Europe Dalbavancin Sales by Application (2027-2032) & (k units) Table 145. Europe Dalbavancin Sales Price by Application (2021-2026) & (US$/unit) Table 146. Europe Dalbavancin Sales Price by Application (2027-2032) & (US$/unit) Table 147. Europe Dalbavancin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Dalbavancin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Dalbavancin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Dalbavancin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 151. Europe Dalbavancin Sales by Country (2021-2026) & (k units) Table 152. Europe Dalbavancin Sales by Country (2027-2032) & (k units) Table 153. Europe Dalbavancin Sales Price by Country (2021-2026) & (US$/unit) Table 154. Europe Dalbavancin Sales Price by Country (2027-2032) & (US$/unit) Table 155. Germany Dalbavancin Revenue (2021-2032) & (US$ Million) Table 156. France Dalbavancin Revenue (2021-2032) & (US$ Million) Table 157. U.K. Dalbavancin Revenue (2021-2032) & (US$ Million) Table 158. Italy Dalbavancin Revenue (2021-2032) & (US$ Million) Table 159. Russia Dalbavancin Revenue (2021-2032) & (US$ Million) Table 160. Spain Dalbavancin Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Dalbavancin Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Dalbavancin Revenue (2021-2032) & (US$ Million) Table 163. Sweden Dalbavancin Revenue (2021-2032) & (US$ Million) Table 164. Poland Dalbavancin Revenue (2021-2032) & (US$ Million) Table 165. China Dalbavancin Revenue by Type (2021-2026) & (US$ Million) Table 166. China Dalbavancin Revenue by Type (2027-2032) & (US$ Million) Table 167. China Dalbavancin Sales by Type (2021-2026) & (k units) Table 168. China Dalbavancin Sales by Type (2027-2032) & (k units) Table 169. China Dalbavancin Sales Price by Type (2021-2026) & (US$/unit) Table 170. China Dalbavancin Sales Price by Type (2027-2032) & (US$/unit) Table 171. China Dalbavancin Revenue by Application (2021-2026) & (US$ Million) Table 172. China Dalbavancin Revenue by Application (2027-2032) & (US$ Million) Table 173. China Dalbavancin Sales by Application (2021-2026) & (k units) Table 174. China Dalbavancin Sales by Application (2027-2032) & (k units) Table 175. China Dalbavancin Sales Price by Application (2021-2026) & (US$/unit) Table 176. China Dalbavancin Sales Price by Application (2027-2032) & (US$/unit) Table 177. Asia Dalbavancin Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Dalbavancin Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Dalbavancin Sales by Type (2021-2026) & (k units) Table 180. Asia Dalbavancin Sales by Type (2027-2032) & (k units) Table 181. Asia Dalbavancin Sales Price by Type (2021-2026) & (US$/unit) Table 182. Asia Dalbavancin Sales Price by Type (2027-2032) & (US$/unit) Table 183. Asia Dalbavancin Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Dalbavancin Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Dalbavancin Sales by Application (2021-2026) & (k units) Table 186. Asia Dalbavancin Sales by Application (2027-2032) & (k units) Table 187. Asia Dalbavancin Sales Price by Application (2021-2026) & (US$/unit) Table 188. Asia Dalbavancin Sales Price by Application (2027-2032) & (US$/unit) Table 189. Asia Dalbavancin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Dalbavancin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Dalbavancin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Dalbavancin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 193. Asia Dalbavancin Sales by Country (2021-2026) & (k units) Table 194. Asia Dalbavancin Sales by Country (2027-2032) & (k units) Table 195. Asia Dalbavancin Sales Price by Country (2021-2026) & (US$/unit) Table 196. Asia Dalbavancin Sales Price by Country (2027-2032) & (US$/unit) Table 197. Japan Dalbavancin Revenue (2021-2032) & (US$ Million) Table 198. South Korea Dalbavancin Revenue (2021-2032) & (US$ Million) Table 199. India Dalbavancin Revenue (2021-2032) & (US$ Million) Table 200. Australia Dalbavancin Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Dalbavancin Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Dalbavancin Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Dalbavancin Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Dalbavancin Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Dalbavancin Sales by Type (2021-2026) & (k units) Table 206. SAMEA Dalbavancin Sales by Type (2027-2032) & (k units) Table 207. SAMEA Dalbavancin Sales Price by Type (2021-2026) & (US$/unit) Table 208. SAMEA Dalbavancin Sales Price by Type (2027-2032) & (US$/unit) Table 209. SAMEA Dalbavancin Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Dalbavancin Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Dalbavancin Sales by Application (2021-2026) & (k units) Table 212. SAMEA Dalbavancin Sales by Application (2027-2032) & (k units) Table 213. SAMEA Dalbavancin Sales Price by Application (2021-2026) & (US$/unit) Table 214. SAMEA Dalbavancin Sales Price by Application (2027-2032) & (US$/unit) Table 215. SAMEA Dalbavancin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Dalbavancin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Dalbavancin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Dalbavancin Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 219. SAMEA Dalbavancin Sales by Country (2021-2026) & (k units) Table 220. SAMEA Dalbavancin Sales by Country (2027-2032) & (k units) Table 221. SAMEA Dalbavancin Sales Price by Country (2021-2026) & (US$/unit) Table 222. SAMEA Dalbavancin Sales Price by Country (2027-2032) & (US$/unit) Table 223. Brazil Dalbavancin Revenue (2021-2032) & (US$ Million) Table 224. Argentina Dalbavancin Revenue (2021-2032) & (US$ Million) Table 225. Chile Dalbavancin Revenue (2021-2032) & (US$ Million) Table 226. Colombia Dalbavancin Revenue (2021-2032) & (US$ Million) Table 227. Peru Dalbavancin Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Dalbavancin Revenue (2021-2032) & (US$ Million) Table 229. Israel Dalbavancin Revenue (2021-2032) & (US$ Million) Table 230. UAE Dalbavancin Revenue (2021-2032) & (US$ Million) Table 231. Turkey Dalbavancin Revenue (2021-2032) & (US$ Million) Table 232. Iran Dalbavancin Revenue (2021-2032) & (US$ Million) Table 233. Egypt Dalbavancin Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Dalbavancin Distributors List Table 237. Dalbavancin Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Dalbavancin Image Figure 2. Global Dalbavancin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dalbavancin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Intravenous Therapy Image Figure 5. Oral Type Image Figure 6. Global Dalbavancin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dalbavancin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Skin Infection Image Figure 9. Soft Tissue Infection Image Figure 10. Others Image Figure 11. Global Dalbavancin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dalbavancin Revenue (2021-2032) & (US$ Million) Figure 13. Global Dalbavancin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Dalbavancin Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Dalbavancin Revenue Market Share by Region (2021-2032) Figure 16. Global Dalbavancin Sales (2021-2032) & (k units) Figure 17. Global Dalbavancin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Dalbavancin Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Dalbavancin Sales YoY (2021-2032) & (k units) Figure 20. Europe Dalbavancin Sales YoY (2021-2032) & (k units) Figure 21. China Dalbavancin Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Dalbavancin Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Dalbavancin Sales YoY (2021-2032) & (k units) Figure 24. Global Dalbavancin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Dalbavancin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Dalbavancin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dalbavancin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Dalbavancin Revenue Market Share by Type (2021-2032) Figure 30. Global Dalbavancin Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Dalbavancin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dalbavancin Sales Market Share by Type (2021-2032) Figure 33. Global Dalbavancin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dalbavancin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Dalbavancin Revenue Market Share by Application (2021-2032) Figure 36. Global Dalbavancin Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Dalbavancin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dalbavancin Sales Market Share by Application (2021-2032) Figure 39. North America Dalbavancin Revenue Share by Type (2021-2032) Figure 40. North America Dalbavancin Sales Share by Type (2021-2032) Figure 41. North America Dalbavancin Revenue Share by Application (2021-2032) Figure 42. North America Dalbavancin Sales Share by Application (2021-2032) Figure 43. North America Dalbavancin Revenue Share by Country (2021-2032) Figure 44. North America Dalbavancin Sales Share by Country (2021-2032) Figure 45. Europe Dalbavancin Revenue Share by Type (2021-2032) Figure 46. Europe Dalbavancin Sales Share by Type (2021-2032) Figure 47. Europe Dalbavancin Revenue Share by Application (2021-2032) Figure 48. Europe Dalbavancin Sales Share by Application (2021-2032) Figure 49. Europe Dalbavancin Revenue Share by Country (2021-2032) Figure 50. Europe Dalbavancin Sales Share by Country (2021-2032) Figure 51. China Dalbavancin Revenue Share by Type (2021-2032) Figure 52. China Dalbavancin Sales Share by Type (2021-2032) Figure 53. China Dalbavancin Revenue Share by Application (2021-2032) Figure 54. China Dalbavancin Sales Share by Application (2021-2032) Figure 55. Asia Dalbavancin Revenue Share by Type (2021-2032) Figure 56. Asia Dalbavancin Sales Share by Type (2021-2032) Figure 57. Asia Dalbavancin Revenue Share by Application (2021-2032) Figure 58. Asia Dalbavancin Sales Share by Application (2021-2032) Figure 59. Asia Dalbavancin Revenue Share by Country (2021-2032) Figure 60. Asia Dalbavancin Sales Share by Country (2021-2032) Figure 61. SAMEA Dalbavancin Revenue Share by Type (2021-2032) Figure 62. SAMEA Dalbavancin Sales Share by Type (2021-2032) Figure 63. SAMEA Dalbavancin Revenue Share by Application (2021-2032) Figure 64. SAMEA Dalbavancin Sales Share by Application (2021-2032) Figure 65. SAMEA Dalbavancin Revenue Share by Country (2021-2032) Figure 66. SAMEA Dalbavancin Sales Share by Country (2021-2032) Figure 67. Dalbavancin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dalbavancin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Therapy
  • Oral Type
Applications
  • Skin Infection
  • Soft Tissue Infection
  • Others
Companies covered
  • Sanofi
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GSK
  • Amgen
  • Abbvie
  • Johnson
  • Hayao
  • Gilead

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dalbavancin Market by Type
  3. 1.2.1 Global Dalbavancin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Intravenous Therapy
  5. 1.2.3 Oral Type
  6. 1.3 Dalbavancin Market by Application
  7. 1.3.1 Global Dalbavancin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Skin Infection
  9. 1.3.3 Soft Tissue Infection
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dalbavancin Market Dynamics
  1. 2.1 Dalbavancin Industry Trends
  2. 2.2 Dalbavancin Industry Drivers
  3. 2.3 Dalbavancin Industry Opportunities and Challenges
  4. 2.4 Dalbavancin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dalbavancin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dalbavancin Revenue by Region
  3. 3.2.1 Global Dalbavancin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dalbavancin Revenue by Region (2021-2026)
  5. 3.2.3 Global Dalbavancin Revenue by Region (2027-2032)
  6. 3.2.4 Global Dalbavancin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dalbavancin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dalbavancin Sales by Region
  9. 3.4.1 Global Dalbavancin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dalbavancin Sales by Region (2021-2026)
  11. 3.4.3 Global Dalbavancin Sales by Region (2027-2032)
  12. 3.4.4 Global Dalbavancin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dalbavancin Revenue by Manufacturers
  2. 4.1.1 Global Dalbavancin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dalbavancin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dalbavancin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dalbavancin Sales by Manufacturers
  6. 4.2.1 Global Dalbavancin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dalbavancin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dalbavancin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dalbavancin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dalbavancin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dalbavancin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dalbavancin Manufacturers, Product Type & Application
  13. 4.7 Global Dalbavancin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dalbavancin Market CR5 and HHI
  16. 4.8.2 2025 Dalbavancin Tier 1, Tier 2, and Tier 3
5 Dalbavancin Market by Type
  1. 5.1 Global Dalbavancin Revenue by Type
  2. 5.1.1 Global Dalbavancin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dalbavancin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dalbavancin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dalbavancin Sales by Type
  6. 5.2.1 Global Dalbavancin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dalbavancin Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Dalbavancin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dalbavancin Price by Type
6 Dalbavancin Market by Application
  1. 6.1 Global Dalbavancin Revenue by Application
  2. 6.1.1 Global Dalbavancin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dalbavancin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dalbavancin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dalbavancin Sales by Application
  6. 6.2.1 Global Dalbavancin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dalbavancin Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Dalbavancin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dalbavancin Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Dalbavancin Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Dalbavancin Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Dalbavancin Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Dalbavancin Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Dalbavancin Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 GSK
  32. 7.6.1 GSK Company Information
  33. 7.6.2 GSK Business Overview
  34. 7.6.3 GSK Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GSK Dalbavancin Product Portfolio
  36. 7.6.5 GSK Recent Developments
  37. 7.7 Amgen
  38. 7.7.1 Amgen Company Information
  39. 7.7.2 Amgen Business Overview
  40. 7.7.3 Amgen Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Amgen Dalbavancin Product Portfolio
  42. 7.7.5 Amgen Recent Developments
  43. 7.8 Abbvie
  44. 7.8.1 Abbvie Company Information
  45. 7.8.2 Abbvie Business Overview
  46. 7.8.3 Abbvie Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Abbvie Dalbavancin Product Portfolio
  48. 7.8.5 Abbvie Recent Developments
  49. 7.9 Johnson
  50. 7.9.1 Johnson Company Information
  51. 7.9.2 Johnson Business Overview
  52. 7.9.3 Johnson Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Johnson Dalbavancin Product Portfolio
  54. 7.9.5 Johnson Recent Developments
  55. 7.10 Hayao
  56. 7.10.1 Hayao Company Information
  57. 7.10.2 Hayao Business Overview
  58. 7.10.3 Hayao Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hayao Dalbavancin Product Portfolio
  60. 7.10.5 Hayao Recent Developments
  61. 7.11 Gilead
  62. 7.11.1 Gilead Company Information
  63. 7.11.2 Gilead Business Overview
  64. 7.11.3 Gilead Dalbavancin Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Gilead Dalbavancin Product Portfolio
  66. 7.11.5 Gilead Recent Developments
8 North America
  1. 8.1 North America Dalbavancin Market Size by Type
  2. 8.1.1 North America Dalbavancin Revenue by Type (2021-2032)
  3. 8.1.2 North America Dalbavancin Sales by Type (2021-2032)
  4. 8.1.3 North America Dalbavancin Price by Type (2021-2032)
  5. 8.2 North America Dalbavancin Market Size by Application
  6. 8.2.1 North America Dalbavancin Revenue by Application (2021-2032)
  7. 8.2.2 North America Dalbavancin Sales by Application (2021-2032)
  8. 8.2.3 North America Dalbavancin Price by Application (2021-2032)
  9. 8.3 North America Dalbavancin Market Size by Country
  10. 8.3.1 North America Dalbavancin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dalbavancin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dalbavancin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dalbavancin Market Size by Type
  2. 9.1.1 Europe Dalbavancin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dalbavancin Sales by Type (2021-2032)
  4. 9.1.3 Europe Dalbavancin Price by Type (2021-2032)
  5. 9.2 Europe Dalbavancin Market Size by Application
  6. 9.2.1 Europe Dalbavancin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dalbavancin Sales by Application (2021-2032)
  8. 9.2.3 Europe Dalbavancin Price by Application (2021-2032)
  9. 9.3 Europe Dalbavancin Market Size by Country
  10. 9.3.1 Europe Dalbavancin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dalbavancin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dalbavancin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dalbavancin Market Size by Type
  2. 10.1.1 China Dalbavancin Revenue by Type (2021-2032)
  3. 10.1.2 China Dalbavancin Sales by Type (2021-2032)
  4. 10.1.3 China Dalbavancin Price by Type (2021-2032)
  5. 10.2 China Dalbavancin Market Size by Application
  6. 10.2.1 China Dalbavancin Revenue by Application (2021-2032)
  7. 10.2.2 China Dalbavancin Sales by Application (2021-2032)
  8. 10.2.3 China Dalbavancin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dalbavancin Market Size by Type
  2. 11.1.1 Asia Dalbavancin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dalbavancin Sales by Type (2021-2032)
  4. 11.1.3 Asia Dalbavancin Price by Type (2021-2032)
  5. 11.2 Asia Dalbavancin Market Size by Application
  6. 11.2.1 Asia Dalbavancin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dalbavancin Sales by Application (2021-2032)
  8. 11.2.3 Asia Dalbavancin Price by Application (2021-2032)
  9. 11.3 Asia Dalbavancin Market Size by Country
  10. 11.3.1 Asia Dalbavancin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dalbavancin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dalbavancin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dalbavancin Market Size by Type
  2. 12.1.1 SAMEA Dalbavancin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dalbavancin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dalbavancin Price by Type (2021-2032)
  5. 12.2 SAMEA Dalbavancin Market Size by Application
  6. 12.2.1 SAMEA Dalbavancin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dalbavancin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dalbavancin Price by Application (2021-2032)
  9. 12.3 SAMEA Dalbavancin Market Size by Country
  10. 12.3.1 SAMEA Dalbavancin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dalbavancin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dalbavancin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dalbavancin Value Chain Analysis
  2. 13.1.1 Dalbavancin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dalbavancin Production Mode & Process
  6. 13.2 Dalbavancin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dalbavancin Distributors
  9. 13.2.3 Dalbavancin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst